GSK

(Reuters) - GlaxoSmithKline shares rose 6 percent on Thursday after the British drugmaker agreed to pay up to $2.2 billion to settle lawsuits in the United States alleging that the discontinued heartburn drug Zantac causes cancer. The…

(Reuters) - British drugmaker GSK said on Friday it will seek to dismiss an upcoming Zantac lawsuit in Florida where plaintiffs alleged the company's discontinued heartburn drug caused prostate cancer. The move follows a Florida court…

(Reuters) - GlaxoSmithKline shares fell more than 6% on Thursday, a day after the U.S. public health agency narrowed its recommendation for the use of all respiratory syncytial virus (RSV) vaccines and suspended recommending their use in…

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some or all of your investment amount, and may not be suitable for all investors. Cryptocurrency prices are highly…

William Barton U.S. Sen. Elizabeth Warren has slammed GSK (NYSE:GSK) for alleged price-gouging over the marketing of its pediatric asthma drug Flovent HFA and its authorized generic. In a statement released Monday, Warren accused GSK of…

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.GSK is on the hunt for deals in China after the UK drugmaker rebuilt a “very strong” relationship with the government…